投融资数据库
免费查数据
注册送3天会员
首页>投融资
Pluristyx
战略投资
Pluristyx is a firm that supports drug development, regenerative medicine, and cell and gene therapies.The company is based in a Seattle, Washington.In July 2022, Pluristyx, panCELLa and Implant Therapeutics announced a definitive merger agreement.In January 2023, Pluristyx and panCELLa announced the granting of a patent used in their universal, off-the-shelf, induced pluripotent stem cells
基本信息
-
公司全称Pluristyx Inc
-
类型细胞疗法开发工具、技术和服务提供商
-
产业领域医药研发/制造、合同服务、合同研发生产组织（CDMO）
-
公司人数15人以下
-
地址454 N 34Th St, SEATTLE WASHINGTON 98103-8602,; US;
-
联系电话888-588-9935
-
邮箱info@pluristyx.com
-
成立时间2018-01-01
投融资
-
2026-01-03
-
2026-01-03
-
2023-12-21
浙公网安备33011002015279
本网站未发布麻醉药品、精神药品、医疗用毒性药品、放射性药品、戒毒药品和医疗机构制剂的产品信息